GoKawiilGiraffe Bio raises $6.4M to boost copper recovery with engineered biomolecules
Giraffe Bio, a mining biotech startup, has raised a $6.4 million seed round led by Orion Industrial Ventures, with BHP Ventures, Twynam, Air Capital, and Baruch Future Ventures also participating. The company says its mine-specific chemical compounds, produced by engineered microbes in bioreactors, can help mining operations recover up to 5% more copper from heap leaches than conventional methods.
GoKawiil's interpretation of the reporting above, not reported fact.
Unlike rivals such as Endolith or Ceibo that introduce live microbes directly into ore, Giraffe Bio grows microbes separately to manufacture tailored compounds, which it argues avoids the challenge of keeping bacteria alive in harsh mining conditions. With copper demand expected to outstrip supply by 2040 amid AI infrastructure growth and electrification, incremental recovery gains from existing mines could become commercially significant, and the funding suggests investors see promise in biotech approaches to mineral extraction beyond new mine development.
- Giraffe Bio raised a $6.4M seed round led by Orion Industrial Ventures with mining-focused backers including BHP Ventures.
- The startup claims its engineered compounds can boost copper recovery by up to 5%, compared to typical 1-2% gains from competitors.
- Its bioreactor-based approach avoids keeping live microbes in mining environments, differentiating it from rivals like Endolith and Ceibo.
Source: techcrunch.com — Tim De Chant, 2026-10-13
Published there as: “Giraffe Bio aims its bespoke biomolecules at the looming copper shortage”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.